Neuroprotective Peptides in Retinal Disease.
cell death
neuropeptides
neuroprotection
receptors
retina neurodegeneration
retinal neurons
retinal vessels
vertebrate retina
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Aug 2019
01 Aug 2019
Historique:
received:
12
07
2019
revised:
26
07
2019
accepted:
31
07
2019
entrez:
4
8
2019
pubmed:
4
8
2019
medline:
4
8
2019
Statut:
epublish
Résumé
In the pathogenesis of many disorders, neuronal death plays a key role. It is now assumed that neurodegeneration is caused by multiple and somewhat converging/overlapping death mechanisms, and that neurons are sensitive to unique death styles. In this respect, major advances in the knowledge of different types, mechanisms, and roles of neurodegeneration are crucial to restore the neuronal functions involved in neuroprotection. Several novel concepts have emerged recently, suggesting that the modulation of the neuropeptide system may provide an entirely new set of pharmacological approaches. Neuropeptides and their receptors are expressed widely in mammalian retinas, where they exert neuromodulatory functions including the processing of visual information. In multiple models of retinal diseases, different peptidergic substances play neuroprotective actions. Herein, we describe the novel advances on the protective roles of neuropeptides in the retina. In particular, we focus on the mechanisms by which peptides affect neuronal death/survival and the vascular lesions commonly associated with retinal neurodegenerative pathologies. The goal is to highlight the therapeutic potential of neuropeptide systems as neuroprotectants in retinal diseases.
Identifiants
pubmed: 31374938
pii: jcm8081146
doi: 10.3390/jcm8081146
pmc: PMC6722704
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN2015
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : "Departments of Excellence-2018" Program
Références
J Neurochem. 1999 Mar;72(3):1283-93
pubmed: 10037502
Peptides. 2000 Jan;21(1):109-13
pubmed: 10704726
Eur J Pharmacol. 2000 Sep 29;405(1-3):351-63
pubmed: 11033340
Ann N Y Acad Sci. 2000;921:317-20
pubmed: 11193843
Ann N Y Acad Sci. 2000;921:366-9
pubmed: 11193854
Neuroreport. 2001 May 25;12(7):1449-52
pubmed: 11388427
J Clin Neurosci. 2002 Jan;9(1):4-8
pubmed: 11749009
Trends Pharmacol Sci. 2002 Feb;23(2):71-7
pubmed: 11830263
Br J Ophthalmol. 2002 Mar;86(3):311-5
pubmed: 11864890
Naunyn Schmiedebergs Arch Pharmacol. 2002 Mar;365(3):200-9
pubmed: 11882916
J Pharmacol Exp Ther. 2003 Jan;304(1):1-7
pubmed: 12490568
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):578-87
pubmed: 12750875
Vision Res. 2003 Aug;43(17):1805-15
pubmed: 12826104
Lancet Neurol. 2003 Aug;2(8):463-72
pubmed: 12878434
Br J Pharmacol. 2003 Sep;140(1):33-40
pubmed: 12967932
Histol Histopathol. 2003 Oct;18(4):1219-42
pubmed: 12973690
Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1044-50
pubmed: 14586589
Int Rev Cytol. 2003;230:263-90
pubmed: 14692684
Prog Retin Eye Res. 2004 Jan;23(1):91-147
pubmed: 14766318
Cell Tissue Res. 2004 Apr;316(1):99-113
pubmed: 14991397
Regul Pept. 2004 Dec 15;123(1-3):33-41
pubmed: 15518891
Eur J Neurosci. 2004 Nov;20(10):2711-21
pubmed: 15548214
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):933-8
pubmed: 15728550
Histol Histopathol. 2005 Apr;20(2):615-32
pubmed: 15736065
Neuropharmacology. 2005 May;48(6):881-93
pubmed: 15829258
Prog Retin Eye Res. 2005 Jul;24(4):457-91
pubmed: 15845345
Neuroscience. 2006;138(2):487-99
pubmed: 16388914
Peptides. 2006 Jun;27(6):1349-58
pubmed: 16406202
Neuropeptides. 2006 Feb;40(1):65-75
pubmed: 16414116
Eur J Neurosci. 2006 May;23(9):2404-22
pubmed: 16706848
Physiol Rev. 2006 Jul;86(3):747-803
pubmed: 16816138
Ann N Y Acad Sci. 2006 Jul;1070:535-9
pubmed: 16888221
Ann N Y Acad Sci. 2006 Jul;1070:550-60
pubmed: 16888224
Trends Endocrinol Metab. 2006 Oct;17(8):301-7
pubmed: 16934485
Peptides. 2006 Dec;27(12):3370-6
pubmed: 16956695
Front Neuroendocrinol. 2007 Apr;28(1):1-27
pubmed: 17083971
Lancet. 2006 Nov 11;368(9548):1696-705
pubmed: 17098089
Diabetes Care. 2007 Mar;30(3):725-7
pubmed: 17327350
Eur J Neurosci. 2007 Mar;25(5):1447-59
pubmed: 17425570
Pharmacol Ther. 2007 Nov;116(2):322-41
pubmed: 17719647
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4342-50
pubmed: 17724226
J Mol Neurosci. 2007;33(3):278-83
pubmed: 17952637
Exp Eye Res. 2008 Feb;86(2):314-21
pubmed: 18096157
Mol Cell Endocrinol. 2008 May 14;286(1-2):112-22
pubmed: 18242820
Neuroscience. 2008 Mar 3;152(1):97-105
pubmed: 18249070
Kidney Int. 2008 May;73(10):1114-9
pubmed: 18272958
Br J Pharmacol. 2008 May;154(1):136-43
pubmed: 18311190
J Ocul Pharmacol Ther. 2008 Apr;24(2):117-40
pubmed: 18355128
Gen Comp Endocrinol. 2008 May 1;156(3):613-21
pubmed: 18358475
Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1255-63
pubmed: 18414890
J Mol Neurosci. 2008 Nov;36(1-3):16-25
pubmed: 18483879
J Clin Invest. 2008 Jun;118(6):2291-300
pubmed: 18497878
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2589-98
pubmed: 18515588
Peptides. 2008 Sep;29(9):1561-5
pubmed: 18550223
J Neurochem. 2008 Sep;106(5):2224-35
pubmed: 18624922
Neurosci Lett. 2008 Oct 10;443(3):218-22
pubmed: 18687380
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):699-706
pubmed: 19084986
Endocrinology. 2009 Jun;150(6):2758-66
pubmed: 19213842
Diabetes. 2009 Jun;58(6):1382-90
pubmed: 19289456
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3853-9
pubmed: 19324855
J Neurochem. 2009 Jun;109(5):1508-15
pubmed: 19344373
Gen Comp Endocrinol. 2009 Sep 1;163(1-2):63-9
pubmed: 19344664
Diabetes. 2009 Jul;58(7):1625-33
pubmed: 19389828
Mol Vis. 2009;15:920-6
pubmed: 19421410
Neurosci Lett. 2009 May 8;455(1):42-5
pubmed: 19429103
Neurosci Lett. 2009 Aug 21;460(1):87-91
pubmed: 19463895
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5800-4
pubmed: 19608537
Pharmacol Rev. 2009 Sep;61(3):283-357
pubmed: 19805477
Curr Med Chem. 2009;16(33):4462-80
pubmed: 19835562
Eur J Pharmacol. 2010 Jan 10;626(1):27-48
pubmed: 19837055
Results Probl Cell Differ. 2010;50:137-84
pubmed: 19859675
Regul Pept. 2010 Nov 30;165(1):123-7
pubmed: 20138192
J Ocul Pharmacol Ther. 2010 Feb;26(1):31-5
pubmed: 20148660
Eur J Neurosci. 2010 Mar;31(5):864-75
pubmed: 20180841
Biomed Pharmacother. 2010 Jul;64(6):417-23
pubmed: 20359852
Prog Retin Eye Res. 2010 Jul;29(4):284-311
pubmed: 20380890
Curr Diab Rep. 2010 Aug;10(4):270-5
pubmed: 20535647
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):539-56
pubmed: 20632972
Ann N Y Acad Sci. 2010 Jul;1200:128-39
pubmed: 20633141
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):278-85
pubmed: 20688733
Clin Exp Ophthalmol. 2011 May-Jun;39(4):324-9
pubmed: 21070547
J Ophthalmol. 2011;2011:506137
pubmed: 21076532
Gen Comp Endocrinol. 2011 May 15;172(1):140-50
pubmed: 21185293
Eur J Pharmacol. 2011 Jun 11;660(1):125-30
pubmed: 21208602
Eur J Pharmacol. 2011 Jun 11;660(1):213-9
pubmed: 21208604
Invest Ophthalmol Vis Sci. 2011 May 02;52(6):2897-904
pubmed: 21245403
Invest Ophthalmol Vis Sci. 2011 Apr 20;52(5):2577-83
pubmed: 21282567
Acta Ophthalmol. 2011 Mar;89(2):e126-31
pubmed: 21288307
J Neurosci. 2011 Feb 2;31(5):1873-84
pubmed: 21289197
Endocrinology. 2011 Apr;152(4):1661-9
pubmed: 21303958
Prog Retin Eye Res. 2011 May;30(3):149-66
pubmed: 21352947
Acta Ophthalmol. 2011 Jun;89(4):e320-6
pubmed: 21470377
Curr Pharm Des. 2011;17(10):962-72
pubmed: 21524257
Curr Vasc Pharmacol. 2011 Sep;9(5):594-605
pubmed: 21529330
J Neuroimmunol. 2011 Jul;236(1-2):1-9
pubmed: 21640392
Growth Horm IGF Res. 2011 Aug;21(4):219-27
pubmed: 21705251
Neurosci Lett. 2011 Aug 26;501(2):83-5
pubmed: 21763400
Mol Ther. 2012 Jan;20(1):28-36
pubmed: 21792177
Acta Ophthalmol. 2012 May;90(3):e250-2
pubmed: 22151476
J Neurochem. 2012 Mar;120(5):818-29
pubmed: 22168912
Exp Eye Res. 2012 Mar;96(1):116-23
pubmed: 22200488
Peptides. 2012 Feb;33(2):298-306
pubmed: 22240274
Peptides. 2012 Apr;34(2):349-52
pubmed: 22369720
PLoS One. 2012;7(3):e33864
pubmed: 22470485
Peptides. 2012 Jul;36(1):142-50
pubmed: 22537944
Neurochem Int. 2012 Jul;61(1):1-6
pubmed: 22542771
J Mol Neurosci. 2012 Nov;48(3):501-7
pubmed: 22544514
Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4289-98
pubmed: 22661469
Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4099-110
pubmed: 22661470
Peptides. 2012 Sep;37(1):25-31
pubmed: 22727809
Curr Pharm Des. 2012;18(37):6101-8
pubmed: 22747547
Eye (Lond). 2012 Oct;26(10):1378-83
pubmed: 22878444
Int J Mol Sci. 2012;13(7):8430-48
pubmed: 22942712
Curr Eye Res. 2013 Jan;38(1):185-93
pubmed: 22954336
Exp Eye Res. 2012 Oct;103:90-8
pubmed: 22960304
Jpn J Ophthalmol. 2013 Jan;57(1):126-32
pubmed: 23093313
Chem Biodivers. 2012 Nov;9(11):2367-87
pubmed: 23161624
Front Endocrinol (Lausanne). 2012 Nov 23;3:145
pubmed: 23189073
Peptides. 2013 Jan;39:119-24
pubmed: 23220033
Diabetes Res Clin Pract. 2013 Feb;99(2):158-67
pubmed: 23332048
Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1816-28
pubmed: 23404122
Diabetes. 2013 Jul;62(7):2569-78
pubmed: 23474487
J Mol Neurosci. 2013 Jul;50(3):558-70
pubmed: 23504281
Neurochem Res. 2013 Aug;38(8):1572-9
pubmed: 23624827
Cell Death Dis. 2013 May 16;4:e636
pubmed: 23681231
Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4296-306
pubmed: 23702784
Curr Neuropharmacol. 2013 Jan;11(1):95-101
pubmed: 23814541
Regul Pept. 2013 Nov 10;187:12-6
pubmed: 24045094
J Diabetes Complications. 2013 Nov-Dec;27(6):531-7
pubmed: 24051030
PLoS One. 2013 Oct 01;8(10):e76365
pubmed: 24098484
Prog Neurobiol. 2014 Jan;112:70-9
pubmed: 24184719
Neurochem Int. 2014 Jan;64:84-91
pubmed: 24262293
Acta Physiol Hung. 2014 Mar;101(1):67-76
pubmed: 24311224
J Neurosci. 2014 Jan 29;34(5):1868-78
pubmed: 24478366
J Mol Neurosci. 2014 Nov;54(3):395-404
pubmed: 24488575
Mol Biosyst. 2014 Jun;10(6):1290-304
pubmed: 24514073
Curr Med Chem. 2014;21(23):2591-8
pubmed: 24533805
Endocrine. 2014 Jun;46(2):209-14
pubmed: 24627166
Free Radic Biol Med. 2014 Jun;71:176-85
pubmed: 24662196
PLoS One. 2014 Apr 02;9(4):e93433
pubmed: 24695675
Eur J Pharmacol. 2014 Jun 15;733:13-22
pubmed: 24704373
Exp Eye Res. 2014 May;122:110-8
pubmed: 24709336
J Mol Neurosci. 2014 Nov;54(3):293-9
pubmed: 24723665
Gen Comp Endocrinol. 2014 Jul 1;203:274-80
pubmed: 24755186
Invest Ophthalmol Vis Sci. 2014 May 22;55(6):3809-18
pubmed: 24854854
BMB Rep. 2014 Jul;47(7):369-75
pubmed: 24856828
Exp Eye Res. 2014 Oct;127:104-16
pubmed: 24910901
PLoS One. 2014 Jun 26;9(6):e100954
pubmed: 24968134
Cell Death Dis. 2014 Jul 17;5:e1333
pubmed: 25032856
Invest Ophthalmol Vis Sci. 2014 Sep 04;55(9):6090-100
pubmed: 25190662
Mol Ther. 2014 Dec;22(12):2069-82
pubmed: 25228068
PLoS One. 2014 Oct 06;9(10):e108090
pubmed: 25286089
PLoS One. 2014 Oct 17;9(10):e110397
pubmed: 25329670
Front Cell Neurosci. 2014 Oct 20;8:333
pubmed: 25368550
Biomol Concepts. 2014 Jun;5(3):225-43
pubmed: 25372755
Cutan Ocul Toxicol. 2015;34(4):307-12
pubmed: 25430074
Gen Comp Endocrinol. 2015 Sep 1;220:103-11
pubmed: 25448258
Mol Vis. 2014 Nov 05;20:1557-68
pubmed: 25489228
J Biol Rhythms. 2015 Feb;30(1):35-41
pubmed: 25512304
N Am J Med Sci. 2014 Dec;6(12):625-32
pubmed: 25599050
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1193-201
pubmed: 25628311
Wound Repair Regen. 2015 Mar-Apr;23(2):268-77
pubmed: 25682893
J Anim Sci Biotechnol. 2015 Feb 12;6(1):8
pubmed: 25774292
Prog Retin Eye Res. 2015 Jul;47:19-37
pubmed: 25797468
Neurochem Res. 2015 Jul;40(7):1402-9
pubmed: 25975365
Drug Des Devel Ther. 2015 Jun 02;9:2819-29
pubmed: 26082612
Oxid Med Cell Longev. 2015;2015:970156
pubmed: 26175842
J Mol Neurosci. 2015 Dec;57(4):501-9
pubmed: 26202258
Cell Mol Biol Lett. 2015 Jun;20(2):265-78
pubmed: 26204407
Peptides. 2015 Oct;72:202-7
pubmed: 26275482
ASN Neuro. 2015 Aug 26;7(4):null
pubmed: 26311075
J Neurophysiol. 2015 Oct;114(4):2431-8
pubmed: 26311183
Diabetes. 2016 Jan;65(1):172-87
pubmed: 26384381
Braz J Med Biol Res. 2015 Dec;48(12):1109-14
pubmed: 26421871
J Clin Endocrinol Metab. 1989 Jan;68(1):160-7
pubmed: 2642484
PLoS One. 2015 Oct 27;10(10):e0141137
pubmed: 26505191
Sci Rep. 2015 Oct 28;5:15812
pubmed: 26507936
Prog Neurobiol. 2017 Aug;155:120-148
pubmed: 26542398
Neurotox Res. 2016 Apr;29(3):432-46
pubmed: 26739825
Gen Comp Endocrinol. 2016 Aug 1;234:81-7
pubmed: 26828817
Gen Comp Endocrinol. 2016 Aug 1;234:151-60
pubmed: 27036926
Gen Comp Endocrinol. 2016 Aug 1;234:57-67
pubmed: 27064058
Gen Comp Endocrinol. 2016 Aug 1;234:68-80
pubmed: 27129619
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2584-92
pubmed: 27163772
Exp Eye Res. 2016 Oct;151:203-11
pubmed: 27212443
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3066-76
pubmed: 27286364
Anat Sci Int. 2016 Sep;91(4):313-24
pubmed: 27324639
J Cell Physiol. 2017 May;232(5):1079-1085
pubmed: 27486932
Acta Diabetol. 2016 Dec;53(6):957-964
pubmed: 27552833
Sci Rep. 2016 Aug 25;6:31912
pubmed: 27558087
J Mol Neurosci. 2016 Oct;60(2):186-94
pubmed: 27566170
Mol Vis. 2016 Aug 12;22:1015-23
pubmed: 27582624
Eur J Pharmacol. 2016 Nov 15;791:213-220
pubmed: 27590359
J Cell Physiol. 2017 May;232(5):1209-1215
pubmed: 27661459
Neurol Res. 2017 Jan;39(1):65-72
pubmed: 27786097
J Mol Neurosci. 2017 Feb;61(2):256-266
pubmed: 27909871
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14396-14401
pubmed: 27911838
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6683-6691
pubmed: 27936470
PLoS One. 2016 Dec 12;11(12):e0167853
pubmed: 27942008
Mol Vis. 2016 Dec 30;22:1522-1531
pubmed: 28050125
J Pharmacol Sci. 2017 Jan;133(1):34-41
pubmed: 28087150
Neuroscience. 2017 Apr 21;348:1-10
pubmed: 28215987
Int J Mol Sci. 2017 Mar 21;18(3):
pubmed: 28335564
Oxid Med Cell Longev. 2017;2017:2949102
pubmed: 28337247
Clin Exp Pharmacol Physiol. 2017 Jul;44(7):803-814
pubmed: 28429852
J Cell Physiol. 2018 Feb;233(2):1120-1128
pubmed: 28436035
Peptides. 2017 Jun;92:1-8
pubmed: 28450048
Exp Eye Res. 2017 Jul;160:56-61
pubmed: 28456446
J Comp Neurol. 2019 Jan 1;527(1):133-158
pubmed: 28472856
Biomed Res Int. 2017;2017:5856071
pubmed: 28593174
Exp Eye Res. 2017 Aug;161:124-131
pubmed: 28603014
Adv Neurobiol. 2017;15:403-425
pubmed: 28674991
Eur J Pharmacol. 2017 Oct 5;812:57-63
pubmed: 28687197
Curr Neuropharmacol. 2018;16(7):993-1003
pubmed: 28714394
Exp Eye Res. 2017 Nov;164:46-54
pubmed: 28734673
Diabetologia. 2017 Nov;60(11):2285-2298
pubmed: 28779212
Peptides. 2017 Nov;97:64-69
pubmed: 28964802
Pharmacol Res. 2018 Feb;128:167-178
pubmed: 28970178
Exp Eye Res. 2018 Jan;166:1-12
pubmed: 29030174
Int J Med Sci. 2017 Sep 19;14(12):1203-1212
pubmed: 29104476
Biomed Pharmacother. 2018 Jan;97:1061-1065
pubmed: 29136785
Neuropeptides. 2018 Feb;67:63-70
pubmed: 29174113
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13248-13253
pubmed: 29180438
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6113-6122
pubmed: 29222553
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6489-6499
pubmed: 29288267
Mol Vis. 2017 Dec 13;23:933-943
pubmed: 29296073
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):487-498
pubmed: 29368003
Front Cell Neurosci. 2017 Dec 12;11:395
pubmed: 29375312
Cell Physiol Biochem. 2018;45(2):505-522
pubmed: 29402864
Exp Eye Res. 2018 Apr;169:157-169
pubmed: 29407222
Clin Exp Ophthalmol. 2018 Sep;46(7):783-795
pubmed: 29442423
J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):119-128
pubmed: 29451852
Gen Comp Endocrinol. 2018 Sep 1;265:111-120
pubmed: 29454595
Physiol Rev. 2018 Apr 1;98(2):813-880
pubmed: 29488822
J Headache Pain. 2018 Mar 2;19(1):19
pubmed: 29500688
Int J Mol Sci. 2018 Mar 29;19(4):null
pubmed: 29596316
Neurotoxicology. 2018 May;66:185-194
pubmed: 29604313
Diabetes Obes Metab. 2018 Sep;20(9):2304-2308
pubmed: 29707863
Acta Pharmacol Sin. 2019 Feb;40(2):170-179
pubmed: 29904091
J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318789323
pubmed: 30126320
Biosci Rep. 2018 Sep 25;38(5):
pubmed: 30177523
Acta Ophthalmol. 2018 Dec;96(8):812-820
pubmed: 30218483
Curr Pharm Des. 2018;24(30):3534-3542
pubmed: 30246634
J Cell Physiol. 2019 Apr;234(4):5230-5240
pubmed: 30374973
J Mol Neurosci. 2019 Jul;68(3):465-474
pubmed: 30415445
Front Mol Neurosci. 2018 Nov 26;11:426
pubmed: 30534050
J Mol Neurosci. 2019 Jul;68(3):397-407
pubmed: 30542799
Exp Eye Res. 2019 Mar;180:63-74
pubmed: 30543793
Acta Biochim Biophys Sin (Shanghai). 2019 Jan 1;51(1):51-58
pubmed: 30566576
Int J Nanomedicine. 2018 Dec 18;14:45-55
pubmed: 30587984
Exp Eye Res. 2019 Apr;181:61-71
pubmed: 30633923
Front Mol Neurosci. 2019 Jan 11;11:493
pubmed: 30687008
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):770-778
pubmed: 30795011
Front Neurosci. 2019 Feb 11;13:87
pubmed: 30804746
Diabetologia. 2019 Jun;62(6):1074-1086
pubmed: 30838453
Cell Biol Int. 2019 Jun;43(6):582-592
pubmed: 30958602
J Mol Neurosci. 2019 Jul;68(3):475-484
pubmed: 30993644
Exp Cell Res. 2019 Jul 15;380(2):115-123
pubmed: 30995434
Neurochem Int. 2019 Sep;128:94-105
pubmed: 31002893
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1459-68
pubmed: 8641849
Ann N Y Acad Sci. 1996 Dec 26;805:489-98
pubmed: 8993429
Ups J Med Sci. 1997;102(1):35-40
pubmed: 9269042
Neurosci Lett. 1997 Dec 5;238(3):127-30
pubmed: 9464636
Eur J Pharmacol. 1998 May 1;348(1):1-10
pubmed: 9650825
Biochem Biophys Res Commun. 1998 Oct 20;251(2):471-6
pubmed: 9792798
Brain Res. 1998 Oct 26;809(1):127-36
pubmed: 9795184